Biotech Values

[DewDiligence]

On today’s webcast, MRX showcased an array of dermatologists and plastic surgeons who said they would have no part of any treatment that purported to be permanent. This is consistent with what I’ve gleaned from my own DD.

Elizabeth Hurley notwithstanding, I submit that Artes Medical is likely to be left at the starting gate in the dermal-filler market.